StockpollyBeta
Get App
Popularity #911
AXSM · NASDAQ · Biotechnology

Axsome Therapeutics (AXSM)

Developer of CNS medicines for depression, Alzheimer’s agitation, daytime sleepiness, and migraine.

$195.44
vs last close−7.66 (−3.77%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue58727587105119121150171196191218
Cost of revenue7768811101312121514
Gross profit5164697996108112137159184176205
113162136157159181169173205213240254
Research & development293137504555455040495346
83879910496113121130150169185208
Selling & marketing00000003641000
General & administrative00000009410901850
Other expenses1450418133−715−520
Operating income−62−98−67−78−63−73−57−37−46−29−63−50
−1−1−1−1−2−2−2−12−11−1−2
Interest income000000000200
Interest expense111122221112
Other non-operating income000000080−200
Income before tax−63−99−68−79−65−75−59−49−47−28−65−51
Income tax expense−1000000−10000
Net income from continuing operations−62−99−68−79−65−75−59−48−47−29−65−51
Net income−62−99−68−79−65−75−59−48−47−29−65−51
EPS, basic−$1.32−$2.08−$1.44−$1.67−$1.34−$1.54−$1.22−$0.97−$0.94−$0.56−$1.26−$0.99
EPS, diluted−$1.32−$2.08−$1.44−$1.67−$1.34−$1.54−$1.22−$0.97−$0.94−$0.56−$1.26−$0.99
Weighted average shares, basic474747484849494950515152
Weighted average shares, diluted474747484849494950515152
EBITDA−60−97−65−76−61−71−55−43−44−25−61−50
Depreciation & amortization222222222220
EBIT−62−98−67−78−63−73−57−45−46−27−63−50